Skip to main content

Apollo Neuro completes $15 million Series A funding round following year-after-year employee doubling

Apollo Neuro is hoping to use the capital from its Series A to continue building out its product offering, a patented wearable device that aims to help its users relieve stress and improve sleep through the use of finely-tuned vibrations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.